Capital Research Global Investors
ATHN

Capital Research Global Investors’s Athenahealth, Inc. ATHN Stock Holding History

Capital Research Global Investors’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-323,000
Closed -$43.2M – 451
2018
Q3 		$43.2M Sell
323,000
-1,011,500
-76% -$152M 0.01% 351
2018
Q2 		$212M Sell
1,334,500
-291,214
-18% -$43.2M 0.06% 232
2018
Q1 		$233M Sell
1,625,714
-210,000
-11% -$28.7M 0.07% 222
2017
Q4 		$244M Sell
1,835,714
-186,000
-9% -$23.8M 0.07% 213
2017
Q3 		$251M Sell
2,021,714
-20,000
-1% -$2.75M 0.08% 201
2017
Q2 		$287M Buy
2,041,714
+273,660
+15% +$34.2M 0.09% 186
2017
Q1 		$199M Sell
1,768,054
-923,275
-34% -$108M 0.06% 225
2016
Q4 		$283M Sell
2,691,329
-163,026
-6% -$17.5M 0.09% 197
2016
Q3 		$360M Sell
2,854,355
-111,284
-4% -$14.2M 0.12% 170
2016
Q2 		$409M Sell
2,965,639
-42,884
-1% -$5.67M 0.14% 150
2016
Q1 		$418M Hold
3,008,523
– – 0.14% 154
2015
Q4 		$484M Sell
3,008,523
-325,000
-10% -$50.2M 0.17% 135
2015
Q3 		$445M Hold
3,333,523
– – 0.16% 142
2015
Q2 		$382M Buy
3,333,523
+21,700
+0.7% +$2.59M 0.13% 176
2015
Q1 		$395M Hold
3,311,823
– – 0.14% 162
2014
Q4 		$483M Buy
3,311,823
+53,954
+2% +$6.78M 0.16% 145
2014
Q3 		$429M Sell
3,257,869
-15,534
-0.5% -$2.05M 0.15% 154
2014
Q2 		$410M Buy
3,273,403
+909,900
+38% +$118M 0.14% 148
2014
Q1 		$379M Sell
2,363,503
-114,596
-5% -$18.9M 0.14% 155
2013
Q4 		$333M Hold
2,478,099
– – 0.12% 167
2013
Q3 		$269M Hold
2,478,099
– – 0.11% 183
2013
Q2 		$210M Buy
+2,478,099
New +$222M 0.09% 206

Other funds holding ATHN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Capital Research Global Investors's ATHN Position: Q4 2018 in Review

Capital Research Global Investors sold out of Athenahealth, Inc. (ATHN) in Q4 2018, closing a stake of 323,000 shares — an estimated $43.2M sold.

Capital Research Global Investors first reported a position in ATHN in Q2 2013 and held it in 22 quarters. The position peaked at $484M in Q4 2015. 263 funds tracked by Wall St. Rank hold ATHN as of Q4 2018.

  • Capital Research Global Investors reported no remaining Athenahealth, Inc. position as of Q4 2018 after selling out during the quarter.
  • Capital Research Global Investors sold 323,000 Athenahealth, Inc. shares in Q4 2018, an estimated $43.2M.
  • Capital Research Global Investors first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 22 quarters.
  • Capital Research Global Investors's Athenahealth, Inc. position peaked at $484M in Q4 2015.
  • 263 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2018.

Based on Capital Research Global Investors's 13F filing for Q4 2018, filed 14 Feb 2019.